School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, D02PN40, Ireland.
Int J Clin Pharm. 2023 Oct;45(5):1074-1087. doi: 10.1007/s11096-023-01602-z. Epub 2023 Jun 3.
The importance of tapering is increasingly recognised when discontinuing antidepressant medication. However, no previous studies have examined the reporting of antidepressant tapering methods in published studies.
The aim of this study was to assess the completeness of reporting of antidepressant tapering methods in a published systematic review using the Template for Intervention Description and Replication (TIDieR) checklist.
A secondary analysis was conducted of studies included in a Cochrane systematic review that examined the effectiveness of approaches for discontinuing long-term antidepressant use. The completeness of reporting of antidepressant tapering methods in included studies was independently assessed by two researchers using the 12 items from the TIDieR checklist.
Twenty-two studies were included in the analysis. None of the study reports described all checklists items. No study clearly reported what materials had been provided (item 3) or whether tailoring had occurred (item 9). With the exception of providing a name for the intervention or study procedures (item 1), only a minority of studies clearly reported on any of the remaining checklist items.
The findings highlight a lack of detailed reporting of antidepressant tapering methods in published trials to date. This needs to be addressed as poor reporting could hinder replication and adaptation of existing interventions, as well as the potential for successful translation of effective tapering interventions into clinical practice.
在停止使用抗抑郁药物时,逐渐认识到逐渐减少剂量的重要性。然而,以前的研究并未检查已发表的研究中抗抑郁药逐渐减少剂量方法的报告情况。
本研究旨在使用干预措施描述和复制模板(TIDieR)清单评估已发表的系统评价中抗抑郁药逐渐减少剂量方法报告的完整性。
对一项检查停止长期使用抗抑郁药的方法的 Cochrane 系统评价中纳入的研究进行了二次分析。两位研究人员使用 TIDieR 清单的 12 个项目,独立评估纳入研究中抗抑郁药逐渐减少剂量方法报告的完整性。
分析纳入了 22 项研究。没有一份研究报告描述了所有清单项目。没有研究明确报告提供了哪些材料(项目 3)或是否进行了调整(项目 9)。除了干预措施或研究程序的名称(项目 1)外,只有少数研究清楚地报告了其余清单项目中的任何一项。
研究结果强调了迄今为止已发表的试验中缺乏对抗抑郁药逐渐减少剂量方法的详细报告。这需要解决,因为报告不佳可能会阻碍现有干预措施的复制和调整,以及将有效的逐渐减少干预措施成功转化为临床实践的潜力。